08/10/2026
𝐃𝐞𝐞𝐩𝐞𝐧𝐢𝐧𝐠 𝐭𝐡𝐞 𝐀𝐟𝐫𝐢𝐜𝐚𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 | 𝐇𝐨𝐭𝐠𝐞𝐧 𝐒𝐡𝐨𝐰𝐜𝐚𝐬𝐞𝐬 𝐅𝐮𝐥𝐥-𝐒𝐜𝐞𝐧𝐚𝐫𝐢𝐨 𝐈𝐦𝐦𝐮𝐧𝐨𝐚𝐬𝐬𝐚𝐲 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 𝐚𝐭 𝐖𝐇𝐗 𝐉𝐨𝐡𝐚𝐧𝐧𝐞𝐬𝐛𝐮𝐫𝐠 𝟐𝟎𝟐𝟔, 𝐀𝐜𝐜𝐞𝐥𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐄𝐱𝐩𝐚𝐧𝐬𝐢𝐨𝐧 𝐀𝐜𝐫𝐨𝐬𝐬 𝐀𝐟𝐫𝐢𝐜𝐚
From October 6–8, 2026, WHX Johannesburg 2026 is currently being held at the Gallagher Convention Centre in Midrand, Johannesburg, South Africa. As one of Africa’s largest and most influential healthcare exhibitions, the event brings together healthcare professionals, hospital groups, laboratory experts, distributors, and industry decision-makers from across the African continent to explore the latest medical and diagnostic innovations.
Hotgen Biotech is making a strong appearance at Hall 2, Booth K11, showcasing its Full-Scenario Immunoassay Solutions tailored for diverse clinical settings including hospital laboratories, primary healthcare facilities, emergency care, and public health applications. The booth is attracting significant interest from local distributors and industry professionals, underscoring the innovation capabilities and regional adaptability of Chinese IVD brands in the African market.
𝐅𝐮𝐥𝐥-𝐒𝐜𝐞𝐧𝐚𝐫𝐢𝐨 𝐈𝐦𝐦𝐮𝐧𝐨𝐚𝐬𝐬𝐚𝐲 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 𝐀𝐝𝐝𝐫𝐞𝐬𝐬𝐢𝐧𝐠 𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐍𝐞𝐞𝐝𝐬
At the exhibition, Hotgen is highlighting a portfolio of immunodiagnostic products designed for the African market, including the fully automated chemiluminescence immunoassay analyzer C2100, the compact benchtop chemiluminescence system MQ60 smart, and the UPT2800 rapid POCT system. This portfolio spans a wide spectrum of clinical applications—from point-of-care screening in primary and remote settings to high-throughput testing in central laboratories.
The chemiluminescence product line, combining compact benchtop systems with fully automated high-throughput analyzers, meets the testing needs of healthcare facilities of varying sizes. The UPT2800 POCT system, distinguished by its speed and ease of use, is particularly suited for emergency response, primary care, and remote-area screening. Together, these solutions deliver reliable, efficient, and scalable diagnostic performance, offering practical options for laboratories and clinics at different levels across the region.
𝐂𝐡𝐚𝐧𝐧𝐞𝐥 𝐄𝐧𝐠𝐚𝐠𝐞𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐋𝐨𝐜𝐚𝐥 𝐏𝐚𝐫𝐭𝐧𝐞𝐫𝐬𝐡𝐢𝐩 𝐁𝐮𝐢𝐥𝐝𝐢𝐧𝐠
Leveraging the WHX Johannesburg platform—a key gathering for the healthcare industry across Africa—Hotgen is engaging in in-depth one-on-one discussions with distributors, hospital groups, and industry professionals from South Africa and neighboring countries, gaining firsthand insights into local market priorities regarding product performance, regulatory registration status, pricing structures, and after-sales support. Multiple cooperation intentions are being established during these conversations, laying a solid foundation for subsequent channel development across the African region.
𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐅𝐨𝐜𝐮𝐬, 𝐒𝐭𝐞𝐚𝐝𝐲 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐦𝐞𝐧𝐭 𝐨𝐟 𝐀𝐟𝐫𝐢𝐜𝐚 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐲
As one of the most promising healthcare markets in Africa and a gateway to the Southern African region, South Africa remains a strategic priority for Hotgen’s global expansion. The Company will continue to deepen collaboration with regional industry organizations and exhibition platforms, accelerate regulatory registration of its products across African markets, and work toward establishing a localized after-sales support framework to better serve the region with solutions that are closely attuned to local needs.
Looking ahead, Hotgen remains committed to strengthening its regional presence through innovative diagnostic technologies and localized partnership models, contributing to the advancement of healthcare across Africa.
𝐄𝐯𝐞𝐧𝐭 𝐒𝐧𝐚𝐩𝐬𝐡𝐨𝐭
• 𝐄𝐯𝐞𝐧𝐭: WHX Johannesburg 2026 (World Health Expo)
• 𝐃𝐚𝐭𝐞: October 6–8, 2026
• 𝐕𝐞𝐧𝐮𝐞: Hall 2, Booth K11, Gallagher Convention Centre, Midrand, Johannesburg, South Africa
